Warren Buffett Detailed Fundamental Analysis

Validea's guru fundamental report reveals Lululemon Athletica Inc. (LULU) scores 79% on its 'Patient Investor' model, which is based on Warren Buffett's strategy for identifying companies with predictable profitability, low debt, and reasonable valuations. While the large-cap apparel retailer largely passes key fundamental criteria such as earnings predictability, debt service, and free cash flow, its 79% rating falls just below the 80% threshold typically indicating 'some interest' for this value-oriented approach, primarily due to a 'fail' in initial rate of return, suggesting strong underlying fundamentals but a valuation that slightly tempers its appeal for this specific strategy.

Analysis

Lululemon Athletica Inc. (LULU) exhibits strong underlying business fundamentals according to Validea's 'Patient Investor' model, which is based on Warren Buffett's investment principles. The company scores a 79% rating, placing it just below the 80% threshold that typically signifies interest from this value-oriented strategy. LULU successfully passes critical tests for long-term health and profitability, including earnings predictability, low debt service requirements, high return on equity, and strong return on total capital. Furthermore, the company demonstrates positive free cash flow, effective use of retained earnings, and a commitment to share repurchases, all of which are hallmarks of a quality operation. However, the analysis identifies a key weakness: the stock fails the 'Initial Rate of Return' criterion. This specific failure suggests that while Lululemon is a fundamentally sound, high-quality company, its current market valuation may not be sufficiently attractive to generate the expected returns required by this particular disciplined, value-focused investment model.

Key Decisions for Investors

• Value-oriented investors should note that despite strong fundamentals, LULU's failure on the 'Initial Rate of Return' metric suggests the current stock price may not offer a sufficient margin of safety.
• Investors with a growth or quality focus may view the strong passes on earnings predictability, ROE, and capital management as a positive signal, but should remain cognizant that the valuation is a potential headwind.
• Consider placing LULU on a watchlist, as a potential market pullback or price correction could improve its valuation and align it more closely with the 'Patient Investor' model's criteria, creating a more compelling entry point.